Venture Capital INDUSTRIES

WilmerHale has been a trusted adviser to innovators, entrepreneurs and investors in technology and life sciences for more than 50 years.


Startup companies and leading investors throughout the United States and Europe rely on WilmerHale to take their ventures from founding and funding to market leadership and successful IPO or exit. Our experience advising venture-backed companies over five decades enables us to deliver guidance that is practical, business oriented and cost effective.

Our clients trust us to help them navigate the wide variety of legal challenges that arise when building a successful business. We draw on the firm's leading intellectual property, technology licensing, privacy and data security, employment, regulatory compliance, and financial services practices. And with offices in venture capital hubs including Boston, Washington DC, New York, Palo Alto, San Francisco, London, Berlin and Beijing, we provide unmatched service and responsiveness to clients. We also participate actively in local startup ecosystems, regularly facilitating introductions between investors and founders and hosting educational and social events.

Contacts

Sort By
Gammell, David

David D. Gammell

Co-Chair, Emerging Company Practice

+1 617 526 6839 (t)

david.gammell@wilmerhale.com

Buckland, Peter

Peter Buckland

Vice Chair, Corporate Practice Group

Co-Chair, Emerging Company Practice

+1 650 858 6036 (t)

peter.buckland@wilmerhale.com

Bain, Mick

Mick Bain

Co-Chair, Corporate Practice Group

+1 617 526 6158 (t)

michael.bain@wilmerhale.com

Experience

Venture capital is a cornerstone of our corporate practice. We represent venture-backed companies and venture capital firms in industries such as big data and data analytics, software as a service, digital media, cybersecurity, robotics, financial technology, semiconductors and electronics, telecommunications and networking, life sciences, biotechnology, healthcare technology, energy, material science and many others. We leverage our global position to best serve our clients' needs and lend perspective to their business deals.

We regularly work with investors and entrepreneurs on financings ranging from seed to growth equity, venture debt, and complex strategic partner financings. We also advise leading venture capitalists on fund formation.

Our extensive experience with emerging technology companies enables us to efficiently manage standard venture capital financings and effectively navigate more complex transactions. Most importantly, we provide clients with a consistent team that provides reliable advice as they build their businesses, drawing on our deep experience in fields including intellectual property, privacy and data security, licensing, labor and employment, environmental, litigation, real estate, and tax law.

We provide advice in context. Our legal experience is bolstered by technical and scientific domain knowledge from attorneys with degrees in fields such as biochemistry, biology, biomedical engineering, chemical engineering, chemistry, computer science, electrical engineering, genetics, immunology, information systems, material science, mathematics, mechanical engineering, medicine, microbiology, nuclear engineering, physics, organic chemistry and systems engineering.

Highlights

Our preeminent Venture Capital Practice consistently ranks in the top tier of law firms measured by the number of venture capital-backed companies we represent in the United States, and in Europe.

Since 2006, we have handled more than 2,800 venture financings with total proceeds in excess of $35 billion. In 2016 alone, we served as counsel in approximately 250 venture financings raising nearly $3 billion, including some of the largest and most prominent deals of the year.

Additional venture capital highlights.

Publications & News

View

April 26, 2017

WilmerHale Counsels Syros Pharmaceuticals in $35M Private Placement

Syros Pharmaceuticals, a biopharmaceutical company pioneering the discovery and development of medicines to control the expression of disease-driving genes, announced that it has entered into a stock purchase agreement with several institutional accredited investors.

April 25, 2017

Cool Planet Closes on Nearly $20M to Fund Commercialization of Engineered Biocarbon Products

WilmerHale counseled agriculture technology company Cool Planet in the closing of a $19.3 million Series A financing to commercialize its Cool Terra and Cool Fauna engineered biocarbon products.

April 10, 2017

WilmerHale Counsels RightHand Robotics in Raising $8M in Equity Financing

RightHand Robotics, a leader in providing end-to-end solutions that reduce the cost of e-commerce order-fulfillment of industries including electronics, apparel, grocery and pharmaceuticals, announced it has raised $8 million in equity financing.

April 7, 2017

Insurance Navigator Wellthie Looks Beyond Healthcare With $5M Series A Round

Wellthie, an insurance technology company offering leading broker and carrier shopping tools to simplify insurance distribution for small businesses and individuals, received $5 million in a Series A round of financing.

March 10, 2017

WilmerHale Counsels HoloBuilder in $2.25M Venture Capital Financing

The Internet software and services company announced the closing of a $2.25 million venture capital financing.

March 8, 2017

President Trump Signs Revised Immigration Executive Order

On March 6, 2017, President Trump signed a substantially narrowed version of the January 27, 2017 Executive Order titled “Protecting the Nation from Foreign Terrorist Entry into the United States.”

March 1, 2017

Selected 2017 Venture Financings As Company Counsel

In 2016, we served as counsel in approximately 250 venture financings raising nearly $3 billion, including some of the largest and most prominent deals of the year.

February 21, 2017

WilmerHale Advises Immuta in $8M Series A Funding

Immuta, the unified data platform for the world's most secure organizations, announced an $8 million Series A round bringing the company's total funding to $9.5 million to date.

February 16, 2017

WilmerHale Counsels Dedrone in Securing $15M Series B Funding

Dedrone, a company offering security solutions addressing airspace vulnerabilities exploited by the advances in consumer and commercial drone technology, announced it has secured $15 million for its Series B funding round.

February 3, 2017

Park Square and WilmerHale Release 17th Annual Technology and Life Sciences Compensation and Entrepreneurship Study

Growth rate in salaries for private company technology executives track higher than comparable life science leaders for the second year in a row.